U.S. flag

An official website of the United States government

NIH: Fogarty International Center NIH: Fogarty International Center
Advancing Science for Global Health
Advancing Science for Global Health
Home > Funding > Funding Newsletter for Global Health Researchers > Funding news for global health researchers November 8, 2021 Print

COVID-19: COVID-19 public health information from the US CDC | COVID-19 research information from the US NIH | Español | COVID-19 resources for global health researchers

Funding news for global health researchers November 8, 2021

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Funding Opportunities

NIH funding opportunities focusing on global health and foreign collaboration.

  • RePORT International Coordinating Center (RICC) (U01 Clinical Trial Not Allowed) (RFA-AI-21-078)
    Application Receipt Date: March 17, 2022

NIH funding opportunities for which foreign organizations may apply.

  • Clinical Trial Readiness for Functional Neurological Disorders (U01 Clinical Trial Optional) (PAR-22-053)
    Application Receipt Date: Multiple dates, see announcement.
  • Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed) (PAR-22-054)
    Application Receipt Date: February 23, 2022
  • Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed) (PAR-22-061)
    Application Receipt Date: Multiple dates, see announcement.
  • Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed) (PAR-22-062)
    Application Receipt Date: Multiple dates, see announcement.
  • Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) (RFA-CA-22-003)
    Application Receipt Date: Multiple dates, see announcement.
  • Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) (RFA-CA-22-004)
    Application Receipt Date: Multiple dates, see announcement.

NIH Notices of Special Interest (NOSIs) that may be of interest to global health researchers.

  • Notice of Special Interest (NOSI): Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (NOT-CA-22-001)

Other Funding News

NIH funding news that may be relevant to global health researchers.

  • Notice of Correction in Expiration Date for PAR-22-049, "Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)" (NOT-CA-22-008)
  • Notice of Change to Eligibility of Foreign Components for RFA-CA-21-047, "Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required)" (NOT-CA-22-009)
  • Request for Information (RFI): Inviting comments and suggestions on the development of a healthy aging start-up challenge and bootcamp to foster diversity and accelerate innovation. (NOT-AG-21-062)

Upcoming Deadlines